logo

For the Inventor, By the Inventor

Chadstone, Australia

Cellestis Limited


USPTO Granted Patents = 14



Trademarks = 4

Forward Citations = 17

Loading Chart...
Loading Chart...

15 inventors (with patents filed for the assignee):

goldMedal Francesca Mariani (6 out of 6 patents)

silverMedal Massimo Amicosante (6 out of 8 patents)

bronzeMedal Vittorio Colizzi (6 out of 8 patents)

4.  Cesare Saltini (6 out of 6 patents)

5.  Jeff Boyle (6 out of 7 patents)

6.  Emily Manktelow (2 out of 3 patents)

7.  Ashley Knights (2 out of 2 patents)

8.  Carmen Munian (2 out of 2 patents)

9.  Anthony J Radford (1 out of 2 patents)

10.  Jenny Louise Howard (1 out of 2 patents)

11.  Rachel De Las Heras (1 out of 1 patent)

12.  Stephen L Jones (1 out of 1 patent)

13.  Steven Paul Wild (1 out of 1 patent)

14.  James Stuart Rothel (1 out of 2 patents)

15.  Angela Cosgriff (1 out of 1 patent)


14 patents:

1. 12181476 - Use of amino acid sequences fromor corresponding nucleic acids for diagnosis and prevention of tubercular infection, diagnostic kit and vaccine therefrom (2024-12-31),
2. 12153042 - Cell mediated immune response assay (2024-11-26),
3. 11841367 - TLR agonist-enhanced in vitro assay of cell mediated immune responsiveness (2023-12-12),
4. 11275086 - Use of amino acid sequences fromor corresponding nucleic acids for diagnosis and prevention of tubercular infection, diagnostic kit and vaccine therefrom (2022-03-15),
5. 10788491 - Use of amino acid sequences fromor corresponding nucleic acids for diagnosis and prevention of tubercular infection, diagnostic kit and vaccine therefrom (2020-09-29),
6. 10564150 - Cell mediated immune response assay (2020-02-18),
7. 10551380 - TLR agonist-enhanced in vitro assay of cell mediated immune responsiveness (2020-02-04),
8. 10408833 - Use of amino acid sequences fromor corresponding nucleic acids for diagnosis and prevention of tubercular infection, diagnostic kit and vaccine therefrom (2019-09-10),
9. 9983207 - Cell mediated immune response assay with enhanced sensitivity (2018-05-29),
10. 9829490 - [object Object] (2017-11-28),
11. 9459253 - Assay for measuring cell-mediated immunoresponsiveness (2016-10-04),
12. 9110061 - Use of amino acid sequences from mycobacterium tuberculosis or corresponding nucleic acids for diagnosis and prevention of tubercular infection, diagnostic kit and vaccine therefrom (2015-08-18),
13. 8871508 - Cell-mediated immune response assay and kits therefor (2014-10-28),
14. 7608392 - Diagnostic assay for measuring a cell mediated immune response (2009-10-27),
Cellestis Limited is a biotechnology company specializing in innovative diagnostic solutions. Established in 2000, Cellestis has been at the forefront of developing and commercializing the QuantiFERON technology, a ground-breaking blood test for diagnosing latent tuberculosis infection. With a mission to improve global healthcare, Cellestis also offers additional diagnostic products and services for infectious diseases. Their commitment to research, development, and quality has made Cellestis a trusted name in the field of molecular diagnostics.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

14 Patents

#1 in Chadstone

#268 in Australia

#40,962 in the World

...
Chadstone, Australia

Cellestis Limited

Forward Citations = 17

15 inventors:

goldMedal Francesca Mariani (6 out of 6 patents)

silverMedal Massimo Amicosante (6 out of 8 patents)

bronzeMedal Vittorio Colizzi (6 out of 8 patents)

4.  Cesare Saltini (6 out of 6 patents)

5.  Jeff Boyle (6 out of 7 patents)

Please report any incorrect information to support@idiyas.com
Loading…